We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App




Neuromodulation Device Helps Treat Overactive Bladder

By HospiMedica International staff writers
Posted on 12 Apr 2016
A novel neuromodulation device targets bladder and brain miscommunication to help tens of millions struggling with overactive bladder (OAB).

The NURO system delivers minimally invasive percutaneous tibial neuromodulation (PTNM), a periodic, office-based procedure that can provide a measurable reduction in urinary frequency, urinary incontinence, and urge incontinence episodes, without the side effects of medication. More...
The device works by delivering a gentle electrical pulse to the tibial nerve via an acupuncture-like needle placed in the skin near the ankle, which is attached to the neurostimulator. The electrical stimulation is thought to indirectly activate the central nervous system (CNS) to help alleviate OAB symptoms.

The therapy is administered in a physician’s office during weekly 30-minute sessions for 12 weeks, and thereafter as prescribed. Side effects are temporary, and include mild pain or skin inflammation at or near the stimulation site. In clinical trials, PTNM reduced the number of incontinence episodes and voids, the urgency and urge of incontinence episodes, and increased voiding volume. The NURO system is a product of Medtronic (Dublin, Ireland), and has been approved by the US Food and Drug Administration (FDA).

“So many suffer from OAB, and the majority are either not treated or not finding relief with other treatments, so Medtronic is pleased to offer another option along the care pathway,” said Linnea Burman, vice president and general manager of gastro/urology therapies at Medtronic. “Our hope is that our expanding neuromodulation portfolio can help a broader range of patients get their lives back.”

“Many people with OAB are unsatisfied with current treatments and a significant number are not seeking treatment altogether,” said Harriette Scarpero, MD, of Associated Urologists of Nashville (TN, USA). “With the NURO System, I can offer patients another option to restore bladder function and improve quality of life without the side effects of medication. This minimally invasive therapy targets the brain-bladder miscommunication and can help improve quality of life in a meaningful way.”

OAB affects more than 37 million people in the United States alone, with a significant impact on their quality of life due to disrupted social activities, unsettled exercise, and excessive nighttime voiding that affects sleep. Despite this, only 33% of those suffering seek treatment, and as many as 70% stop using their medications within six months, due to intolerable side effects or unsatisfying results.

Related Links:

Medtronic



Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
High-Precision QA Tool
DEXA Phantom
New
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The milli-spinner can shrink blood clots without rupturing them (Photo courtesy of Andrew Brodhead/Stanford)

New Technology More Than Doubles Success Rate for Blood Clot Removal

In cases of ischemic stroke, where a blood clot obstructs oxygen supply to the brain, time is critical. The faster the clot is removed and blood flow restored, the more brain tissue can be saved, improving... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.